k3 cancer

You know, I keep saying that some of my orthodox colleagues are coming round to our way of thinking. I dissociate myself from silly, petulant “holistic” writers who think everything is evil about conventional cancer treatment. For the twentieth time or more, I repeat: there are some great doctors out there, trying hard. Not everyone is corrupted by Big Pharma. Now even the FDA is playing ball with them! I’m talking now about a novel combination of vitamin C and vitamin K3 called Apatone. It selectively targets tumors by entering cancer cells as readily as glucose. It then suppresses certain inflammatory reactions that cancer cells use to escape destruction by chemotherapy agents. When administered prior to chemo, vitamin K3 appears to decrease the resistance to chemo drugs. It has helped prostate cancer patients, who were getting no help from chemo, to start making progress knocking out the cancer. That’s vitamin C and vitamin K3 at work. According to Science News, “This non-toxic approach weakens and kills cancers in a novel way.”1 In fact quite a few studies published since 2008 have shown vitamins K2 and K3 to be intriguing agents in both cancer prevention and treatment. In a March 2008 study, Apatone significantly slowed the cancer; 16 our of 17 patients responded positively (no chemo agent can equal that!) Moreover, of the 15 patients who continued to take it, only one death occurred after 14 months of treatment. The doses were: 5,000 mg of vitamin C and 50 mg of vitamin K3. The doctors concluded that Apatone showed promise in delaying biochemical progression in this group of end stage prostate cancer patients.2

You know, I keep saying that some of my orthodox colleagues are coming round to our way of thinking. I dissociate myself from silly, petulant “holistic” writers who think everything is evil about conventional cancer treatment. For the twentieth time or more, I repeat: there are some great doctors out there, trying hard. Not everyone is corrupted by Big Pharma. Now even the FDA is playing ball with them! I’m talking now about a novel combination of vitamin C and vitamin K3 called Apatone. It selectively targets tumors by entering cancer cells as readily as glucose. It then suppresses certain inflammatory reactions that cancer cells use to escape destruction by chemotherapy agents. When administered prior to chemo, vitamin K3 appears to decrease the resistance to chemo drugs. It has helped prostate cancer patients, who were getting no help from chemo, to start making progress knocking out the cancer. That’s vitamin C and vitamin K3 at work. According to Science News, “This non-toxic approach weakens and kills cancers in a novel way.”1 In fact quite a few studies published since 2008 have shown vitamins K2 and K3 to be intriguing agents in both cancer prevention and treatment. In a March 2008 study, Apatone significantly slowed the cancer; 16 our of 17 patients responded positively (no chemo agent can equal that!) Moreover, of the 15 patients who continued to take it, only one death occurred after 14 months of treatment. The doses were: 5,000 mg of vitamin C and 50 mg of vitamin K3. The doctors concluded that Apatone showed promise in delaying biochemical progression in this group of end stage prostate cancer patients.2